SG3 Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
EP
SG3 Management's ARKG Position: Q3 2021 in Review
SG3 Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2021, closing a stake of 12,000 shares — an estimated $1.01M sold.
SG3 Management first reported a position in ARKG in Q4 2020 and held it in 3 quarters. The position peaked at $22.8M in Q4 2020. 469 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.
- SG3 Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2021 after selling out during the quarter.
- SG3 Management sold 12,000 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $1.01M.
- SG3 Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 3 quarters.
- SG3 Management's ARK Genomic Revolution ETF position peaked at $22.8M in Q4 2020.
- 469 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.
Based on SG3 Management's 13F filing for Q3 2021, filed 15 Nov 2021.